Global Medication Management Market Set To Grow To $2.0 In 2022

06 August 2018
Pharma

Visiongain has launched a new pharma report Global Medication Management Market to 2027: System & Software, Services, Mode of Delivery, Computerised Physician Order Entry, Clinical Decision Support System, Medication Administration Software, Automated Dispensing System, Medication Analytics, Point of Care Verification, Adverse Drug Event Surveillance

The future of the medication management market looks promising, as more and more healthcare providers adopt medication management solutions to reduce the complications in drug administration. Medication management systems are used in hospitals and pharmacies for the prescribing and administering of medicines. Demand for advanced healthcare information and remote patient monitory will propel the medication management market.

The lead analyst of the report commented - “The global medication management market will see steady growth over the forecast period. Growth in the market is primarily driven by the increasing adoption of medication management solutions by hospitals and pharmacies to reduce medication errors, increase in number of prescriptions and increased health care expenditure. However, high costs associated with implementing software and timely gradation and maintenance of these systems may deplete the market to a certain extent.
Asia Pacific is expected to experience the fastest growth owing to large population pool, increased prevalence of infectious diseases, and continued commitment by the government and healthcare providers for better healthcare services.’’

Leading companies featured in the report include Cerner Corporation, GE Healthcare, Epic Systems Corporation, Allscripts Healthcare Solutions, McKesson Corporation, Siemens AG, Braun Melsungen AG, Oracle Corporation, Qualcomm Incorporated, Becton, Dickinson and Company.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Generic Drugs market set to grow to $424bn by 2024” says new Visiongain report

Visiongain believes the market will see more traditional pharma companies beginning to embrace the generic business in order to take advantage of higher growth rates in this area.

14 June 2019

Read

“Global Precision Cancer Diagnostic Tests market set to grow to $21.3bn by 2024” says new Visiongain report

The market players are increasingly focusing on precision therapies where drug and precision tests are developed simultaneously.

06 June 2019

Read

“Global Antifungal Drugs market set to grow to $17bn by 2024” says new Visiongain report

Market penetration and adoption of new technologies entering the market for antifungal drugs will be crucial for market growth.

04 June 2019

Read

“Global Ophthalmic Equipment market set to grow to $75bn by 2024” says new Visiongain report

here is a growing demand for ophthalmic equipment such as vision care products and ophthalmology surgical devices, mainly due to the increasing incidence of myopia across the world.

03 June 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever